ArticleScience progress2021
Urgent call for mass immunization against coronavirus in Bangladesh.
Article in Science progress, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed.
- Mapping Mpox vaccine hesitancy using an integrated machine learning and structural equation modeling approach.Scientific reports · 2026Article
- Article
- COVID-19 vaccination uptake in remote areas-Evidence from a panel survey in Bangladesh.PloS one · 2024Article
- Article
- Assessment of risk perception and subjective norms related to Mpox (monkeypox) among adult males in Bangladesh: A cross-sectional study.Health science reports · 2023Article
- COVID-19 vaccination success in Bangladesh: Key strategies were prompt response, early drives for vaccines, and effective awareness campaigns.Health science reports · 2023Article
- Risk evaluation and mitigation strategies for newly detected SARS-CoV-2 Omicron BF.7 subvariant: A brief report.Health science reports · 2023Article
- Article
- Article
- The latest Omicron BA.4 and BA.5 lineages are frowning toward COVID-19 preventive measures: A threat to global public health.Health science reports · 2022Article
- Burden of COVID-19 on health and wellbeing, education, and economy of Bangladesh.Clinical case reports · 2022Article
- Prevalence and associated factors for elevated fear and depressive symptoms among the private service holders in Bangladesh during the Covid-19 pandemic: A cross-sectional study.Health science reports · 2022Article
- A systematic review and meta-analysis of abnormalities in hematological and biochemical markers among Bangladeshi COVID-19 cases.Health science reports · 2022Article
- Comparative evaluation of authorized drugs for treating Covid-19 patients.Health science reports · 2022Article
- The SARS-CoV-2 omicron wave is indicating the end of the pandemic phase but the COVID-19 will continue.Journal of medical virology · 2022Article
- The SARS-CoV-2 Omicron (B.1.1.529) variant and effectiveness of existing vaccines: What we know so far.Journal of medical virology · 2022Article
- Turning point: A new global COVID-19 wave or a signal of the beginning of the end of the global COVID-19 pandemic?Immunity, inflammation and disease · 2022Review
- Increased suicidal behaviors among students during COVID-19 lockdowns: A concern of student's mental health in Bangladesh.Journal of affective disorders reports · 2022Article
- The SARS-CoV-2 Omicron (B.1.1.529) variant and the re-emergence of COVID-19 in Europe: An alarm for Bangladesh.Health science reports · 2022Article
- Emerging SARS-CoV-2 Variants and Subvariants: Challenges and Opportunities in the Context of COVID-19 Pandemic.Environmental health insights · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bangladesh showed initial success in the mass inoculation drive. However, the program was going through an alarming situation when the serum institute of India halted the shipments. Now the authority is administering US Moderna vaccines, Chinese Sinopharm vaccines, and Pfizer vaccines. Mass immunization is the only way for Bangladesh besides the present COVID-19 responses. Therefore, Bangladesh can utilize its previous experience in the roll-out of mass vaccination. The country can search for all available alternatives of COVID-19 vaccines besides maintaining diplomatic consistency with the existing sources for early vaccination of its population. The authority can try to get the committed vaccines from the COVAX program. Also, the country needs to maintain diplomatic relations with other global alliances that are promising support to poor and developing countries for the COVID-19 vaccine. The government can also consider direct purchases from vaccine manufacturers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.